SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950159-21-000369
Filing Date
2021-12-27
Accepted
2021-12-27 16:01:21
Documents
2
Group Members
MVM GP (NO. 5) LPMVM V LP

Document Format Files

Seq Description Document Type Size
1 MVM PARTNERS LP SCHEDULE 13D mvmsc13d.htm SC 13D 90392
2 EXHIBIT 1 ex1.htm EX-1 5656
  Complete submission text file 0000950159-21-000369.txt   97563
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Subject) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90169 | Film No.: 211520371
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 ST. GEORGE STREET LONDON X0 W1S SFH
Business Address 30 ST. GEORGE STREET LONDON X0 W1S SFH 44 20 7557 7500
MVM Partners LLP (Filed by) CIK: 0001893459 (see all company filings)

IRS No.: 980594767 | State of Incorp.: X0 | Fiscal Year End: 0331
Type: SC 13D